RESUMEN
【Objective】 To investigate the prevalence of occult hepatitis C virus infection (OCI) in Shaanxi blood donors and characterize the occult hepatitis C virus in this cohort. 【Methods】 Between July and September of 2019, 112, 117, 46, and 75 blood samples were obtained from eligible donors, alanine aminotransferase (ALT) elevated donors(ALT>50 U/L), hepatitis B virus surface antigen (HBsAg) positive donors, and anti-hepatitis C virus (anti-HCV) positive donors, respectively. Peripheral blood lymphocytes (PBMCs) were isolated from all the samples. HCV 5′UTR was amplified from total RNA of PBMCs using reverse transcription nested PCR (RT-Nested PCR) to detect the infection status of OCI in blood donors. HCV RNA core/E2 region was amplified from HCV RNA positive samples with RT-Nested PCR to determine HCV genotypes and subtypes via sequencing. 【Results】 Two (2.67%, 2/75) cases of OCI were identified in anti-HCV positive samples, 1(0.85%, 1/117) case of OCI was identified in abnormal ALT samples, and all OCI were genotyped as 1b. OCI was not found in HBsAg positive and eligible blood donors. 【Conclusions】 Our findings suggest that OCI does exist among Shaanxi blood donors and that ALT may be useful in diagnosing OCI.
RESUMEN
Recientemente, se ha descrito un nuevo escenario clínico denominado hepatitis C oculta (HCV-Oc); este solo puede ser caracterizado mediante análisis del genoma viral, ya que marcadores serológicos por prueba de ELISA no son detectables. En este trabajo se pretendió identificar el virus de la hepatitis C (HCV) en un paciente retrasplantado por falla hepática de origen desconocido. Para esto, ARN obtenido de los explantes, muestras de suero, plasma y buffy coat, fue analizado mediante una RT-PCR que amplifica la región 5UTR del HCV, demostrando la presencia del genoma viral solo en el tejido hepático de ambos explantes; al analizar las secuencias, los aislados fueron caracterizados como genotipo 1a.Este estudio obedece al primer reporte en el mundo de HCV-Oc causada por el genotipo 1a del HCV, en un paciente que debió ser trasplantado. Se recomienda tener en cuenta este nuevo escenario para el diagnóstico diferencial en cirrosis hepática, carcinoma hepatocelular y/o falla hepática de origen desconocido.
A new clinical scenario called Occult Hepatitis C Virus infection has been recently described (HCV-Oc); it can only be characterized by molecular analysis, due that serological marker by ELISA are not detected.The aim of the present study was to identify the Hepatitis C Virus infection in a patient re-transplanted by hepatic failure of unknown etiology. For this, RNA obtained from different sources (Liver tissue, serum, plasma and buffy coat) was assessed by a RT-PCR protocol that specifically targeted the HCV 5UTR, showing the presence of HCV genome just in liver tissue explants. When viral sequences were analyzed, the strains belonged to HCV genotype 1a. Our study corresponds to the first report in the world of HCV-Oc due to HCV genotype 1a, in liver re-transplantation context. We recommend having in mind this new clinical scenario into the differential diagnosis of patients with cirrhosis, hepatocellular carcinoma and/or hepatic failure of unknown etiology.